By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: RNAi Firm Raises Funds to Develop Drugs That Turn Off Disease-Causing Genes
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Business > Finance > RNAi Firm Raises Funds to Develop Drugs That Turn Off Disease-Causing Genes
FinanceMedical InnovationsTechnology

RNAi Firm Raises Funds to Develop Drugs That Turn Off Disease-Causing Genes

Deanna Pogorelc
Deanna Pogorelc
Share
2 Min Read
SHARE

RNAiFirst published on MedCityNews.com. Just a few years ago, several big companies abandoned their RNAi drug development efforts, finding it difficult to deliver drugs that use the RNAi method for silencing genes.

RNAiFirst published on MedCityNews.com. Just a few years ago, several big companies abandoned their RNAi drug development efforts, finding it difficult to deliver drugs that use the RNAi method for silencing genes. Recently, though, the market seems to be on the rebound.

A San Diego startup developing a siRNA drug delivery system for the orphan disease market is further evidence of that. To expand its team and work toward choosing a lead clinical candidate next year, Arcturus Therapeutics has just rounded up $5 million from angel investors in Canada, Japan and the United States.

RNA interference is a technique that uses small snippets of RNA to silence a cell’s expression of genes and viruses that cause disease. Arcturus is developing a lipid nanoparticle drug delivery system that leverages small interfering RNA, which can bind to specific messenger RNA molecules and increase or decrease their activity. It’s using that system to develop a pipeline of new therapeutics for orphan diseases, beginning with a rare liver disease.

More Read

Image
Person-Centered HealthCare; FDA Approves EarlySense Bedside System
Benefits Of Wearing Stylish Medical Alert Bracelets
Health Care Costs and the Medical Malpractice Myth
Doctors 2.0 & You Videos: Serious Games – Jurriaan van Rijswijk, Jennifer Stinson and Oxana Kolosova
Google Helpouts: Live Video Competition or Marketing Opportunity?

Since its $1.3 million seed round closed early this summer, the company has licensed a portfolio of Marina Biotech’s unlocked nucleic acid technology.

Two former employees of Nitto Denko, Joseph Payne and Pad Chivukula, started Arcturus earlier this year. It’s one of 18 life sciences companies located at Janssen Labs, an innovation center in San Diego that provides startups access to wet labs and research and administrative equipment.

Global Industry Analysts estimates that the market for RNAi technologies, with leaders like Alnylam Pharmaceuticals and Silence Therapeutics, will reach $4 billion by 2017.

TAGGED:RNA
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

dental care
Importance of Good Dental Care for Health and Confidence
Dental health Specialties
October 2, 2025
AI in Healthcare
AI in Healthcare: Technology is Transforming the Global Landscape
Global Healthcare Policy & Law Technology
October 1, 2025
Choosing the Right Swimwear for Health and Safety
News
September 30, 2025
sports concussions
Concussion In Sports: How Common They Are And What You Need To Know
Infographics
September 28, 2025

You Might also Like

Medical DevicesTechnology

The Important And Powerful Role Of Portable Oxygen Concentrators

April 7, 2020
AHRA 2014 Day 1 Keynote Speaker Lieutenant Colonel Rob “Waldo” Waldman.
RadiologyTechnology

AHRA 2014 Keynote Highlights: Lessons for Your Radiology Department from a Fighter Pilot

August 14, 2014
healthcare ecommerce
Global HealthcareTechnology

The Future of Medicine eCommerce: Revolutionizing Healthcare

December 28, 2023

Coronary Stents Show Clinical and Economic Staying Power

April 18, 2011
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?